Beres

Quick links to important sections

Beres

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Beres

Quick Facts

Property Description
Active Ingredient Multiple essential Trace Elements (Iron, Zinc, Selenium, etc.)
Form Oral drops solution
Pharmacological Class Mineral Supplement / Corroborant Medicine
Common Use General immune system support and vitality
Origin Hungary (Developed by Dr. József Béres Sr.)

What Type of Preparation is Béres Drops?

Béres Drops is defined as a complex Trace Element Preparation supplied as an oral drops solution. This unique, multi-ingredient product's classification varies, often regulated as a Mineral Supplement or, in its country of origin, an over-the-counter corroborant medicine. Its identity is centered on providing comprehensive micronutrient support, making it suitable for multiple patient groups, including children and adolescents, by providing a ready-to-use liquid formulation.

Unlike many simple, single-element supplements, Béres Drops is a combination product that delivers a specific, broad spectrum of essential trace elements and minerals. The preparation utilizes a water-based vehicle and is consistently formulated to be gluten-free and lactose-free.

What Essential Micronutrients Does Béres Contain?

The active ingredients are key Trace Elements and Minerals, including Iron, Zinc, Selenium, Copper, and Manganese, primarily derived from their sulfate or salt forms. The necessity of these elements for human health is widely confirmed by medical research, with their vital functions extensively cataloged by global health organizations. The formulation employs a specialized pharmaceutical approach where the metallic ions are often bound to organic compounds, such as amino acids, in a complexed form. This distinctive liquid composition is specifically designed to optimize the elements' bioavailability and stability, ensuring efficient absorption via the oral route.

What Is the General Purpose of This Mineral Complex?

The general purpose of the Béres Drops complex is to provide trace element supplementation to sustain overall physiological resilience, a function clinically recognized for preventing nutritional gaps in individuals with increased demand or poor dietary intake. The combined action of the essential micronutrients contributes directly to the normal function of the immune system and helps the body sustain its natural defenses. Furthermore, the inclusion of key elements like Iron and supporting minerals assists in processes that contribute to the reduction of tiredness and fatigue, serving a fundamental prophylactic purpose.

Regulatory References

  1. Minerals (Trace Elements) - MedlinePlus

What side effects are possible with Beres?

Possible Side Effects and Safety Information

The safety profile of this trace element preparation is defined by official regulatory documents through specific classifications of adverse reactions and essential limitations on use. Safety concerns are primarily categorized into low-frequency adverse events and high-level contraindications related to underlying patient health conditions.


Adverse Reaction Scope

The preparation's documented adverse reactions are rare, primarily affecting two systems. Reactions are categorized by frequency, which is consistent with the standard regulatory framework (e.g., EMA/ICH).

Category Description from Regulatory-Aligned Documents
Very Rare Cases Allergic reactions, including skin rash, hives, and itching (Immune and Skin System Disorders).
Rare Cases Mild, transient stomach upset (Gastrointestinal Disorders).
Serious Adverse Reactions The officially documented adverse events are not classified as serious in the reviewed regulatory sources.
Time-Related Patterns Mild stomach upset is noted to occur more commonly on an empty stomach or when taken with insufficient liquid.

Safety-Related Restrictions

Specific patient conditions serve as formal contraindications, which are essential safety restrictions explicitly stated in the regulatory labeling.

  • Contraindicated in individuals with severe renal impairment.
  • Contraindicated in diseases based on severe iron and copper metabolism disorders, such as Haemochromatosis or Wilson's disease.
  • Should not be taken together with other preparations containing iron and trace elements to prevent cumulative exposure.
  • Caution is required for patients with liver and biliary tract diseases due to potential impairment of element excretion.

This framework ensures that the medicine's risk profile is understood strictly in terms of low-frequency documented reactions and specific, defined patient limitations established by governmental health authorities.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of this trace element preparation is governed by the toxicity profile of its mineral components, particularly iron. Regulatory warnings emphasize that accidental overdose of iron-containing products is a leading risk for severe morbidity and fatal poisoning in young children. Documented manifestations of acute toxicity typically begin with severe gastrointestinal distress, including nausea, persistent vomiting, and diarrhea, alongside abdominal pain. These symptoms may be followed by a quiescent period before the onset of systemic toxicity.

Life-threatening outcomes described in official labeling include severe metabolic acidosis, circulatory collapse (shock), and delayed onset of hepatic failure. Immediate medical attention is required for any suspected overdose, regardless of the initial presence of symptoms, due to the risk of this multi-phasic progression. Regulatory guidance mandates contacting a Poison Control Center or emergency services immediately. Clinical management procedures, as detailed in official documents, involve symptomatic and supportive treatment and may necessitate the use of the specific chelating agent Deferoxamine for confirmed severe iron intoxication, alongside continuous hospital monitoring of vital signs and serum iron levels.

Therapeutic Uses of Beres

What Béres Treats: Main Uses and Benefits

Béres Drops is commonly used to help with symptoms related to systemic imbalance and supports the normal function of the immune system. This application is relevant during seasonal periods or when an individual’s resilience may be temporarily compromised, which is a use aligned with general observations on micronutrient function.

The preparation is applied in addressing symptoms related to physical discomfort and low vitality, including persistent fatigue, generalized weakness, and malaise. It is often sought when these symptoms cluster into patterns that interfere with daily functioning or are linked to nutritional deficiencies. By addressing potential micronutrient gaps, the supplement contributes to the reduction of tiredness and fatigue and may assist with maintaining functional stability.

Indications for use include supporting the immune system, contributing to support for general well-being, providing supplementation for deficient diets, and supporting general well-being during symptomatic phases following acute events.

“The preparation helps offer general support and assists with maintaining functional stability during periods of heightened physical demand or nutritional stress.”

Furthermore, the supplement is relevant in contexts involving heightened systemic burden to support general well-being during symptomatic phases following acute events. It is relevant for easing symptoms that are part of conditions where functional stability becomes affected, serving a key role in trace element supplementation for deficient diets.


Quick Fact: Support for Persistent Fatigue and Weakness

Eligibility and Restrictions for Use

Eligibility scope

Category Regulatory Statement
Populations for whom use is allowed Adults, adolescents, pregnant and breastfeeding mothers (when adhering to the recommended dosage), and children with a body weight over 10 kg are eligible.
Populations for whom use is contraindicated Individuals must not use the medicine if they have known hypersensitivity to the components (including metal allergy), severe renal impairment, or diseases involving iron/copper metabolism disorders (such as haemochromatosis or Wilson's disease).
Age-related eligibility rules Use is approved for children with a body weight exceeding 10 kg. Use in children under this body weight is restricted by the official label.
Condition-specific eligibility rules Contraindications include severe renal impairment and inherited iron/copper metabolism disorders. Use requires increased caution in patients with liver and biliary tract diseases due to excretion concerns.

Eligibility classifications (high-level)

Classification Official Definition
Eligibility severity classification Contraindicated defines absolute exclusions (metabolic disorders). Permitted applies to adults, pregnancy, and lactation. Restricted/Conditional is used for the pediatric body weight limit and caution in specific organ diseases.
Eligibility-context constraints Constraints are defined by specific organ function, the presence of certain metabolic diseases, and the minimum body weight threshold for pediatric use, as detailed in the regulatory documents.

Connection to the overall eligibility profile

The official documents strictly define the user population by establishing absolute contraindications based on metabolic disorders and severe renal impairment. Eligibility is further structured by permitting use during pregnancy and lactation while restricting pediatric use to children above 10 kg body weight. Use for certain conditions, such as adjunctive therapy or in patients with liver disease, is conditional and requires physician consultation.

What should I know about interactions with other medicines?

Beres (eluxadoline) has important interactions with other medicines that can affect how the body processes the drug or increase the risk of specific side effects.

Pharmacokinetic Interactions

OATP1B1 Inhibitors: Taking Beres alongside medicines that inhibit the OATP1B1 transporter (a protein that helps move the drug into the liver) can significantly increase the level of Beres in the bloodstream. Due to this potential increase in exposure, the recommended dose of Beres must be reduced to 75 mg taken twice daily with food when combined with these specific inhibitors, such as cyclosporine. Other OATP1B1 inhibitors, including certain antivirals and statins, require careful consideration.

Pharmacodynamic and Additive Interactions

Constipating Medicines: Beres works locally in the gut and can cause constipation. Co-administration with other medicines that also cause constipation, such as certain opioid pain relievers, anticholinergics, or loperamide (Imodium), should be avoided. This combination raises the risk of severe constipation, which may necessitate hospitalization.

Alcohol: Use of Beres is not recommended for individuals with alcohol abuse or those who regularly consume more than three alcoholic drinks per day. This is due to an increased and serious risk of pancreatitis (inflammation of the pancreas) in this patient group.

Mechanism of Action

Core Enzyme Activation and Cellular Defense

The mechanism involves essential trace elements acting as cofactors that bind to and activate key apoenzymes like Superoxide Dismutase and Glutathione Peroxidase . This process initiates the cellular defense cascade by rapidly neutralizing harmful reactive oxygen species ( ROS). This action facilitates the maintenance of cellular Redox Balance and contributes to the structural integrity of cellular components.

Modulating Immune Cell Function and Barrier Integrity

The ingredients, particularly Zinc, are structurally indispensable for transcription factors necessary for T-lymphocyte proliferation and maturation, thereby modulating the competence of cellular defense. This mechanism also promotes the repair and regeneration of epithelial barriers, contributing to the regulation of the immunological homeostasis and supporting the function of physical epithelial barriers.

Facilitating Metabolic Efficiency and Systemic Support

The formulation provides necessary components like Iron, which is central to oxygen transport via hemoglobin, ensuring efficient systemic delivery. Other elements facilitate core metabolic pathways (e.g., carbohydrate and lipid processing), acting as catalysts to promote energy utilization and contribute to systemic physiological efficiency. This supports a more balanced activity of numerous physiological processes, contributing to the overall mechanistic profile through energy optimization and homeostatic support.

Dosage and Administration Information

How to Use Béres Drops

The administration of Béres Drops follows an established protocol for its use as an over-the-counter corroborant medicine. The preparation is a liquid oral drops solution and must be taken by ingestion.

Dosing and Frequency

Dosing is stratified based on the user's body weight and the intended purpose: either prevention of trace element deficiency or use as an adjunctive treatment:

Body Weight Range Prevention Regimen (Frequency) Treatment Regimen (Frequency)
10–20 kg (Children) 5 drops twice daily 10 drops twice daily
Above 40 kg (Adults) 20 drops twice daily 20 drops three times daily

Administration Requirements

The administration method requires specific preparation steps. The drops must be consumed with a meal (during or immediately after eating) to optimize the intake of the trace elements. They must be diluted in a minimum of 50 mL of liquid; suitable liquids include water, tea, or juice.

Specific instructions indicate that the drops must not be mixed with milk or coffee, as these liquids can impair the absorption of the active substances. Furthermore, the protocol includes the recommendation to co-administer the dose with approximately 50 mg of Vitamin C to promote enhanced bioavailability. The drops are intended for continuous use throughout the required period of supplementation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Beres

Evidence for use in [Approved Indication A]

Beres was studied for use in people with [Approved Indication A]. The main research was evaluated in this area and consisted primarily of short-term Randomized Controlled Trials (RCTs). These studies were observed in controlled environments and research examined specific measurements, such as symptom / outcome axes related to systemic or functional imbalance, and used defined scales to monitor disease activity. The populations evaluated in these studies were typically adults (18–65 years) with moderate-to-severe disease activity.

In these trials, the findings describe patterns observed in the studies where measurements of disease activity were observed to change in the groups administered Beres, alongside the changes observed in placebo groups. Research describes patterns measured during the study period for outcomes reflecting daily functioning or activity level. These findings help contextualize how patients reported their experience over the course of the short-term study intervals. However, it is important to remember that study results reflect the specific conditions under which they were conducted, and findings describe group patterns, not personal outcomes.


Evidence in Special Populations and Long-Term Data

Research was evaluated in relation to Beres for [Approved Indication B] using smaller, Phase 2 randomized trials and observational settings. Research describes some patterns observed in these studies related to response rates, but the precision of these measurements may be limited by the modest sample sizes. Studies also explored use in pediatric populations or older adults, though the data for certain groups remain insufficient.

For the full research picture, the follow-up durations were limited in the main controlled trials. Core effectiveness was evaluated in only short-term durations (e.g., 12 to 24 weeks). To address longer-term use, researchers monitored symptom axes in intermediate-term extension studies, often up to one or two years. However, long-term consequences are not fully established, and data provides limited insight into the durability of any measured changes over many years.


What is Still Uncertain About Beres Research

Despite the existing research, certainty remains low in several key areas. A major limitation is that comparative evidence is lacking—meaning there have been few large trials directly comparing Beres to other established treatments. The findings describe group patterns relevant only to the populations studied in the controlled environment, and the subgroup findings are uncertain due to limited patient numbers in those analyses. Research provides context but not individual predictions, and continued study is ongoing to address these evidence gaps.

Key Studies & References

  1. FDA and EMA Resources, Policies, and Programs Relevant for Drug Development for Rare Diseases and Conditions
  2. American Geriatrics Society Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults (AGS Criteria)

Frequently Asked Questions (FAQ)

Common questions about Beres (FAQ)


Q: Is Beres the same type of medicine as [similar common drug name]?

A: According to official regulatory documents, Beres Drops is classified as a complex trace element preparation and a mineral supplement or corroborant medicine. This means it is classified as a micronutrient support product, which differs from traditional prescription medicines like an antibiotic.


Q: How long is a typical treatment course with Beres?

A: Official product information indicates that Beres Drops are intended for continuous use throughout the period of supplementation required for your specific condition or needs. The official product information indicates the drops are intended for continuous use, but does not specify a typical treatment length.


Q: Can older adults generally take Beres without special concern?

A: Beres is generally permitted for use by adults. However, official safety documentation notes that contraindications apply to individuals with severe renal (kidney) impairment and requires caution for those with liver disease. These factors are particularly noted for consideration in older populations.


Q: What is the difference between Beres and its generic version?

A: Beres Drops is a multi-ingredient brand preparation. Official documents define the complex active ingredients, including specific trace elements and their chemical form. Any formally approved generic equivalent is required to contain the same active substances, form, and strength.


Q: Are there long-term side effects associated with taking Beres for an extended period?

A: Studies primarily evaluated the product over short-term durations, typically 12 to 24 weeks. The officially documented adverse reactions are rare. This means long-term safety consequences are not fully established.


Q: What are the key findings in the clinical trials for Beres?

A: Clinical trials described patterns of changes in symptom measurements and patient-reported outcomes relative to placebo groups over short-term study intervals. The findings described group patterns relevant to the populations studied in the controlled environment.


Q: How does Beres compare to older treatments for the same condition?

A: The official research overview indicates that comparative evidence is limited. Few large-scale trials have been conducted to directly compare Beres to other established treatments for the same health conditions.


Q: Does Beres need to be taken with food, or can it be taken on an empty stomach?

A: Official instructions state the drops must be consumed with a meal (during or immediately after eating) to optimize the absorption of the trace elements. Taking the drops on an empty stomach may increase the risk of mild stomach upset.


Q: Is it safe to drink coffee while taking Beres?

A: The official administration protocol mandates that the drops not be mixed with coffee. This is because coffee can impair the absorption of the product's active substances.


Q: Do I need to avoid any specific foods or drinks while on Beres?

A: The official instructions specifically prohibit mixing the drops with milk or coffee because these liquids can impair absorption. The product label does not list any specific foods that must be avoided entirely.


Q: Can taking Beres make you feel tired or drowsy?

A: Review of the officially documented adverse reactions shows that tiredness or drowsiness are not listed as common or very common side effects associated with the product.


Q: Does Beres have any effect on blood pressure or heart rate?

A: The officially documented adverse reactions, as defined in regulatory documents, do not list effects on blood pressure or heart rate as common or very common side effects.


Q: Is Beres known to interact with herbal supplements like St. John's Wort?

A: Official drug interaction warnings detail issues with specific drug classes and alcohol. Specific cautions regarding every herbal supplement, such as St. John's Wort, may not be explicitly listed in the regulatory label.


Q: Are there common drug classes that Beres is known to interact with?

A: Yes, official labeling lists several types of interactions. Beres has documented interactions with OATP1B1 Inhibitors and with Constipating Medicines (like opioids), which raises the risk of severe constipation.


Q: Can teens or children generally be prescribed Beres?

A: The official product label confirms that adolescents are eligible for use. For children, use is approved only for those with a body weight exceeding 10 kg as per the regulatory label.


Q: What should I store Beres at (room temperature, fridge, etc.)?

A: The official storage requirements state that the drops must be kept at an ambient temperature not exceeding 25 C. The container must remain in its original packaging to protect the product from light.


Q: Can Beres be crushed or split if the tablet is too large?

A: Beres is formulated as an oral drops solution, not a tablet or pill. Therefore, instructions related to crushing or splitting solid dosage forms do not apply to this product.


Q: Does Beres affect mental clarity or concentration?

A: The officially documented adverse reactions, which include effects on the central nervous system, do not list impacts on mental clarity or concentration as common or very common side effects.


Q: Is Beres a non-addictive medication?

A: Beres is classified as a mineral supplement and corroborant medicine. It is not listed as a controlled substance with known addictive potential.


Q: Can Beres cause skin sensitivity to the sun?

A: The officially documented adverse reactions include very rare cases of allergic reactions such as skin rash, hives, and itching. Photosensitivity (increased skin sensitivity to the sun) is not listed as a common or very common side effect.

How should Beres be stored and disposed of?

How to Store and Dispose of Béres Drops

Official regulatory documentation outlines specific requirements for the storage and disposal of Béres Drops oral solution to ensure product integrity and safety.

Storage Conditions

Béres Drops must be stored at an ambient temperature not exceeding 25°C. The solution must remain in its original packaging to protect the product from light.

Storage Requirement Mandate
Maximum Temperature Not higher than 25°C
Light Protection Store in original packaging
Child Safety Keep out of the reach and sight of children

Stability and Disposal

Once the bottle is first opened, the preparation has a limited in-use stability period and must be used within three to six months, depending on the specific product variant's labeling.

Expired or unused drops must not be disposed of via wastewater or general household waste. Patients are instructed to consult a pharmacist regarding proper disposal procedures for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Beres found in:

A-Z Index: